Current Report Filing (8-k)
March 03 2023 - 8:01AM
Edgar (US Regulatory)
0001839175
false
0001839175
2023-03-02
2023-03-02
0001839175
MBAC:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnethirdOfOneRedeemableWarrantMember
2023-03-02
2023-03-02
0001839175
MBAC:ClassCommonStockParValue0.0001PerShareMember
2023-03-02
2023-03-02
0001839175
MBAC:PublicWarrantsEachWholePublicWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember
2023-03-02
2023-03-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 2, 2023
M3-BRIGADE ACQUISITION II CORP.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-40162 |
|
86-1359752 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
1700 Broadway, 19th Floor
New York, New York 10019
(Address of principal executive offices, including
zip code)
(212) 202-2200
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant |
|
MBAC.U |
|
New York Stock Exchange |
Class A common stock, par value $0.0001 per share |
|
MBAC |
|
New York Stock Exchange |
Public warrants, each whole public warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share |
|
MBAC.WS |
|
New York Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. Entry into Material Definitive Agreement.
On March 2, 2023, M3-Brigade Acquisition Corp.
II (the “Company”) and M3-Brigade Sponsor II LP (the “Sponsor”) entered into non-redemption agreements (“Non-Redemption
Agreements”) with unaffiliated third parties in exchange for such third parties agreeing not to redeem an aggregate of 4,052,653
shares of the Company’s Class A common stock sold in its initial public offering (“Non-Redeemed Shares”) in connection
with the special meeting of stockholders called by the Company (the “Special Meeting”) to consider and approve an extension
of time for the Company to consummate an initial business combination (the “Extension Proposal”) from March 8, 2023 to December
8, 2023 (the “Extension”). In exchange for the foregoing commitments not to redeem such Non-Redeemed Shares, the Sponsor has
agreed to transfer to such third parties an aggregate of 1,013,161 shares of the Company’s Class B common stock held by the Sponsor
promptly upon consummation of the Extension if they continue to hold such Non-Redeemed Shares through the Special Meeting. Pursuant to
the Underwriting Agreement, dated as of March 3, 2021, by and between the Company and Cantor Fitzgerald & Co. (“Cantor Fitzgerald”),
which was filed as Exhibit 1.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on March 9, 2021, Cantor
Fitzgerald has consented in writing to the transfers of the Company’s Class B common stock contemplated by the Non-Redemption Agreements.
In the event
that the Extension Proposal is approved and implemented as described in the definitive proxy statement (the “Proxy Statement”)
for the Special Meeting filed by the Company with the Securities and Exchange Commission (the “SEC”) on February 22, 2023, funds
in the Company’s trust account, including any interest earned thereon, will not be used to pay for any excise tax liabilities with
respect to any redemptions that occur prior to or in connection with a business combination or liquidation of the Company. As further
described in the Proxy Statement, if the Company completes a business combination, because the excise tax would be payable by the Company
(following the business combination) and not by the redeeming holder or out of the trust account, the payment of the excise tax would
reduce cash available to the Company for ongoing operations following the completion of the business combination (and if the Company does
not complete a business combination, the Company would seek to obtain alternative funds if necessary to pay any excise tax incurred by
the Company with respect to any redemptions).
The Non-Redemption Agreements are not expected
to increase the likelihood that the Extension Proposal is approved by Company’s stockholders but are expected to increase the amount
of funds that remain in the Company’s trust account following the Special Meeting, relative to the amount of funds remaining in the
trust account had the Non-Redemption Agreements not been entered into.
The foregoing summary of the Non-Redemption Agreement
does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed as Exhibit
10.1 hereto and incorporated herein by reference.
Participants in the Solicitation
The Company and its directors and executive officers
and other persons may be deemed to be participants in the solicitation of proxies from the Company’s stockholders in respect of
the Extension. Information regarding the Company’s directors and executive officers is available in its annual report on Form 10-K
filed with the SEC. Additional information regarding the participants in the proxy solicitation and a description of their direct and
indirect interests are contained in the Proxy Statement.
No Offer or Solicitation
This communication shall not constitute an offer
to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which
the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of
1933, as amended.
Additional Information
The Company has filed with the SEC the Proxy Statement
to consider and vote upon the Extension and other matters, and, beginning on or about February 22, 2023, first mailed the Proxy Statement
and other relevant documents to its stockholders as of the February 21, 2023 record date for the Special Meeting. The Company’s
stockholders and other interested persons are advised to read the Proxy Statement and any other relevant documents that have been or will
be filed with the SEC in connection with the Company’s solicitation of proxies for the Special Meeting because these documents will
contain important information about the Company, the Extension and related matters. Stockholders may also obtain a free copy of the Proxy
Statement, as well as other relevant documents that have been or will be filed with the SEC, without charge, at the SEC’s website
located at www.sec.gov or by directing a request to Innisfree M&A Incorporated at (877) 800-5182 (toll free) or (212) 750-5833 (bank
and brokers can call collect).
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
EXHIBIT
INDEX
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
M3-BRIGADE ACQUISITION II CORP. |
|
|
|
Date: March 3, 2023 |
By: |
/s/ Mohsin Y. Meghji |
|
|
Name: |
Mohsin Y. Meghji |
|
|
Title: |
Chairman and Chief Executive Officer |
-4-
M3Brigade Acquisition II (NYSE:MBAC)
Historical Stock Chart
From Nov 2024 to Dec 2024
M3Brigade Acquisition II (NYSE:MBAC)
Historical Stock Chart
From Dec 2023 to Dec 2024